Three big letters: P-S-A. In the world of urology and men’s health, perhaps no three letters generate more controversy. Since the early 1990s, the prostate-specific antigen (or PSA) blood test has served as the cornerstone of prostate cancer early detection. Today, it remains at the center of a debate over
Tag: the psa test
The prostate-specific antigen (PSA) blood test remains central to prostate cancer screening and, at the same time, at the center of considerable controversy. While proponents cite data supporting the test as a way to reduce the risk of dying from prostate cancer, critics point to the chain of events that
There is no universally accepted “normal” PSA level. In the past, a PSA of 4 nanograms per milliliter of blood (ng/ml) or less was considered normal; however, more recent studies have shown that some men with PSAs below 4 have prostate cancer and some men with PSAs over 4 do
Some men with prostate cancer do not experience any symptoms of the disease and don’t discover they have it until a screening test returns with a suspicious result, leading to a search for a diagnosis. Other men may experience significant symptoms of prostate cancer, prompting them to seek medical attention.
In May 2012, the U.S. Preventive Services Task Force (USPSTF) recommended against routine prostate cancer screening for all men, focusing instead on screening men at high risk and very high risk. The high risk category includes African Americans, and men with a first-degree relative, (brother, father, son) diagnosed with prostate